药物护理对心力衰竭再入院的影响:一项随机试验
Beatriz Montero-Llorente1, Covadonga Pérez Menéndez-Conde2, Eduardo González Ferrer3
1Pharmacy Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain bmontero@salud.madrid.org.
European journal of hospital pharmacy : science and practice
|November 27, 2024
概括
对心力衰竭患者的持续药物护理对30天的再入院没有显著影响,但在90天内减少了急诊室的访问和再入院. 这突显了药剂师在出院后持续支持药剂师的长期益处.
科学领域:
- 心脏病学 心脏病学
- 临床药房 临床药房
- 医疗保健服务研究 医疗服务研究
背景情况:
- 心力衰竭 (HF) 的管理需要持续监测,以防止医院再入院和急诊室 (ED) 的访问.
- 制药护理模式旨在优化药物管理和患者的治疗结果.
- 评估药剂师主导干预对高频再入院的影响对于医疗保健系统的效率至关重要.
研究的目的:
- 评估持续药物护理计划对30天和90天的再入院和心力衰竭患者退院后急救诊所的影响.
- 为了比较接受标准护理的患者和接受持续护理的干预组患者之间的结果.
主要方法:
- 一项前性,随机化,开放标签,单中心研究,涉及296名心力衰竭患者.
- 患者被随机分配 (1:1) 接受药剂师的标准护理 (控制) 或持续护理模式 (干预).
- 用t测试收集和分析了有关再入院,ED访问和再入院/ED访问的时间的数据.
主要成果:
- 在30天的再接收或ED访问中,两组之间没有显著的差异 (p=0.092).
- 在干预组 (p=0.043) 观察到90天再入院和ED访问的统计显著减少.
- 干预组的第一次再入院或ED访问的时间明显更长 (p=0.021).
结论:
- 对心力衰竭患者的持续药物护理对30天的再入院和急救诊所访问有中性的影响.
- 然而,这种护理模式显示出对减少再入院和急救诊所访问的积极影响,在退院后90天内.
- 持续的药剂师参与改善了心力衰竭患者的长期结果.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
01:22Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
01:26Heart Failure Drugs: Inotropic Agents
521
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
521
01:22Heart Failure Drugs: Diuretics
343
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
343
01:28Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3
01:21Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3